Contact Us

DESTINATION NEWS

Tyligand Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and Orally Bioavailable KRAS G12D Inhibitor

May 30, 2024

SHANGHAI,May 24,2024--Tyligand Bioscience,a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies,announced that the first patient had been dosed

Compassionate closure for those who are unable to fulfil hopes and expectations of fertility treatment

May 30, 2024

MANILA,Philippines,May 24,2024-- Compassionate closure is a vital aspect of the holistic care of millions of people each year who are left with lost hopes and dreams of parenthood after assisted conc

United in Our Fight Against Cancer - New Frontier Group Acquires Hong Kong Integrated Oncology Centre

May 30, 2024

HONG KONG,May 24,2024-- New Frontier Group (hereinafter referred to as "New Frontier") announces today that it has completed the acquisition of Hong Kong Integrated Oncology Centre (hereinaf

Nagad becomes successful unicorn startup within 3 years

May 30, 2024

DHAKA,Bangladesh,May 24,2024-- Within just three years of its inception,Nagad,a leading mobile financial service provider based in Bangladesh,has established itself as the most successful startup uni

61st ERA Congress: Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals

May 30, 2024

STOCKHOLM,May 24,2024-- A pioneering study,presented today at the 61st ERA Congress,has demonstrated that semaglutide significantly reduces the risk of major kidney disease events,cardiovascular outco

Fanttik Day: Celebrating our 4th Anniversary with discounts

May 30, 2024

HOUSTON,Texas,May 26,2024-- Fanttik,the multiple-award-winning auto-accessories brand,is kicking off its largest extravaganza of the year to celebrate its momentous fourth anniversary from May 27 to J

1 ... 337 338 339 340 341 342 343 ... 353